The North America breast implants market size was valued at USD 0.80 Billion in 2024, driven by the growing demand for breast implants in reconstructive surgery for breast cancer survivors along with the rising innovation in breast implant technology in the region. The market is expected to grow at a CAGR of 5.13% during the forecast period of 2025-2034, with the value likely to reach USD 1.32 Billion by 2034.
The surge in the demand for breast augmentation procedures, attributed to aesthetic reasons along with the rising prevalence of breast cancer in the region is likely to boost the North America breast implants market growth in the forecast period. According to the National Breast Cancer Foundation, Inc., around 1 in 8 women are estimated to be diagnosed with breast cancer in their lifetime in the United States. In addition, it is predicted that 310,720 women will be diagnosed with invasive breast cancer in 2024. Thus, the rising cases of breast cancer coupled with the advancements in reconstructive surgery for breast cancer survivors are expected to fuel the market demand in the forecast period.
The improvement in regulatory policies by health authorities such as the United States Food and Drug Administration (FDA) is likely to propel market growth. The availability of innovative products in healthcare facilities is anticipated to positively influence North America breast implants market demand. In October 2023, Establishment Labs Inc., a global medical technology company specializing in Femtech solutions for breast health, breast aesthetics, and breast reconstruction, announced that the FDA granted 510(k) clearance for the Motiva Flora® SmoothSilk® Tissue Expander. Titled as the first-ever magnet-free, and MR conditional breast tissue expander (which permits women to undergo magnetic resonance imaging (MRI)), its application has been approved in the United States market. Compared to other implant surfaces, SmoothSilk® has shown to exhibit minimum foreign body response and inflammation.
One of the significant North America breast implants market trends is the increased investment in the aesthetic surgery sector in order to meet the growing demand for breast augmentation and reconstruction procedures. In June 2023, a growth capital investment was made in Olympus Cosmetic Group (a provider of cosmetic surgery including breast augmentation and cosmetic dermatology procedures in the United States) by VSS Capital Partners, a New York-based private equity firm known for its investment in healthcare. The investment will support the development of this physician-owned platform and help to provide premium outcomes to its patients. Further, these investments also ensure the availability of skilled professionals and high-quality services, which is expected to bolster market growth in the region.
Other factors that impact the market landscape include the rise in technological innovation in breast implant technology, increasing economic growth, and growing disposable incomes in North America which allow more individuals to afford the cosmetic procedure.
This product will be delivered within 3-5 business days.
The surge in the demand for breast augmentation procedures, attributed to aesthetic reasons along with the rising prevalence of breast cancer in the region is likely to boost the North America breast implants market growth in the forecast period. According to the National Breast Cancer Foundation, Inc., around 1 in 8 women are estimated to be diagnosed with breast cancer in their lifetime in the United States. In addition, it is predicted that 310,720 women will be diagnosed with invasive breast cancer in 2024. Thus, the rising cases of breast cancer coupled with the advancements in reconstructive surgery for breast cancer survivors are expected to fuel the market demand in the forecast period.
The improvement in regulatory policies by health authorities such as the United States Food and Drug Administration (FDA) is likely to propel market growth. The availability of innovative products in healthcare facilities is anticipated to positively influence North America breast implants market demand. In October 2023, Establishment Labs Inc., a global medical technology company specializing in Femtech solutions for breast health, breast aesthetics, and breast reconstruction, announced that the FDA granted 510(k) clearance for the Motiva Flora® SmoothSilk® Tissue Expander. Titled as the first-ever magnet-free, and MR conditional breast tissue expander (which permits women to undergo magnetic resonance imaging (MRI)), its application has been approved in the United States market. Compared to other implant surfaces, SmoothSilk® has shown to exhibit minimum foreign body response and inflammation.
One of the significant North America breast implants market trends is the increased investment in the aesthetic surgery sector in order to meet the growing demand for breast augmentation and reconstruction procedures. In June 2023, a growth capital investment was made in Olympus Cosmetic Group (a provider of cosmetic surgery including breast augmentation and cosmetic dermatology procedures in the United States) by VSS Capital Partners, a New York-based private equity firm known for its investment in healthcare. The investment will support the development of this physician-owned platform and help to provide premium outcomes to its patients. Further, these investments also ensure the availability of skilled professionals and high-quality services, which is expected to bolster market growth in the region.
Other factors that impact the market landscape include the rise in technological innovation in breast implant technology, increasing economic growth, and growing disposable incomes in North America which allow more individuals to afford the cosmetic procedure.
North America Breast Implants Market Segmentation
North America breast implants market analysis offers a detailed breakup of the market based on the following segments:Market Breakup by Type:
- Silicone Implants
- Form-Stable Implants
- Saline Implants
- Structured Saline Implants
- Others
Market Breakup by Implant Shape:
- Round
- Anatomical
- Others
Market Breakup by Application:
- Reconstructive Surgery
- Cosmetic Surgery
- Others
Market Breakup by End User:
- Hospitals
- Cosmetology Clinics
- Ambulatory Surgical Centers
- Others
Market Breakup by Region:
- United States of America
- Canada
North America Breast Implants Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:- Establishment Labs SA
- GC Aesthetics
- Groupe Sebbin SAS
- Laboratories Arion
- Silimed
- Johnson & Johnson (Mentor Worldwide LLC)
- HansBioMed
- Cereplas
- Sientra Inc.
- AbbVie Inc. (Allergan PLC)
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 North America Breast Implants Market Overview
4 North America Breast Implants Market Landscape*
5 North America Breast Implants Market Dynamics
6 North America Breast Implants Market Segmentation (2018-2034)
7 United States of America Breast Implants Market (2018-2034)
8 Canada Breast Implants Market (2018-2034)
10 Patent Analysis
11 Funding and Investment Analysis
12 Partnership and Collaborations Analysis
13 Supplier Landscape
14 North America Breast Implants Market - Distribution Model (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
17 Payment Methods (Additional Insight)
Companies Mentioned
- Establishment Labs SA
- GC Aesthetics
- Groupe Sebbin SAS
- Laboratories Arion
- Silimed
- Johnson & Johnson (Mentor Worldwide LLC)
- HansBioMed
- Cereplas
- Sientra Inc.
- AbbVie Inc. (Allergan PLC)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | July 2025 |
| Forecast Period | 2025 - 2034 |
| Estimated Market Value ( USD | $ 0.8 Billion |
| Forecasted Market Value ( USD | $ 1.32 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | North America |
| No. of Companies Mentioned | 10 |
